Theriva Biologics Statistics

Total Valuation

TOVX has a market cap or net worth of $2.86 million. The enterprise value is -$11.81 million.

Market Cap	2.86M
Enterprise Value	-11.81M

Important Dates

The last earnings date was Tuesday, November 12, 2024, before market open.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

TOVX has 2.27 million shares outstanding. The number of shares has increased by 30.03% in one year.

Current Share Class	2.27M
Shares Outstanding	2.27M
Shares Change (YoY)	+30.03%
Shares Change (QoQ)	+46.23%
Owned by Insiders (%)	0.58%
Owned by Institutions (%)	15.53%
Float	1.80M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.13
P/TBV Ratio	0.12
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.67, with a Debt / Equity ratio of 0.07.

Current Ratio	2.67
Quick Ratio	2.51
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -77.91% and return on invested capital (ROIC) is -34.86%.

Return on Equity (ROE)	-77.91%
Return on Assets (ROA)	-24.85%
Return on Capital (ROIC)	-34.86%
Revenue Per Employee	n/a
Profits Per Employee	-$1.21M
Employee Count	22
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-424,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -87.71% in the last 52 weeks. The beta is 1.34, so TOVX's price volatility has been higher than the market average.

Beta (5Y)	1.34
52-Week Price Change	-87.71%
50-Day Moving Average	1.98
200-Day Moving Average	6.78
Relative Strength Index (RSI)	35.64
Average Volume (20 Days)	4,790,779

Short Selling Information

The latest short interest is 90,953, so 4.00% of the outstanding shares have been sold short.

Short Interest	90,953
Short Previous Month	96,864
Short % of Shares Out	4.00%
Short % of Float	5.05%
Short Ratio (days to cover)	0.03

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-20.21M
Pretax Income	-20.35M
Net Income	-26.69M
EBITDA	-20.06M
EBIT	-20.21M
Earnings Per Share (EPS)	-$32.52

Full Income Statement

Balance Sheet

The company has $16.41 million in cash and $1.74 million in debt, giving a net cash position of $14.67 million or $6.46 per share.

Cash & Cash Equivalents	16.41M
Total Debt	1.74M
Net Cash	14.67M
Net Cash Per Share	$6.46
Equity (Book Value)	24.64M
Book Value Per Share	9.41
Working Capital	12.21M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-18.79M
Capital Expenditures	-57,000
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TOVX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-30.03%
Shareholder Yield	-30.03%
Earnings Yield	-932.18%
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for TOVX is $6.00, which is 376.19% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.00
Price Target Difference	376.19%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on August 26, 2024. It was a reverse split with a ratio of 0.04:1.

Last Split Date	Aug 26, 2024
Split Type	Reverse
Split Ratio	0.04:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2